Stock Analysis on Net
Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Beginner level

The balance sheet provides creditors, investors, and analysts with information on company’s resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company’s assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Medtronic PLC, consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in millions

Microsoft Excel LibreOffice Calc
Apr 24, 2020 Jan 24, 2020 Oct 25, 2019 Jul 26, 2019 Apr 26, 2019 Jan 25, 2019 Oct 26, 2018 Jul 27, 2018 Apr 27, 2018 Jan 26, 2018 Oct 27, 2017 Jul 28, 2017 Apr 28, 2017 Jan 27, 2017 Oct 28, 2016 Jul 29, 2016 Apr 29, 2016 Jan 29, 2016 Oct 30, 2015 Jul 31, 2015 Apr 24, 2015 Jan 23, 2015 Oct 24, 2014 Jul 25, 2014
Current debt obligations 2,776  844  875  1,458  838  1,356  1,343  1,545  2,058  2,902  3,131  8,058  7,520  6,226  3,367  1,947  993  2,153  2,158  1,850  2,434  2,185  3,970  2,477 
Accounts payable 1,996  1,945  1,965  1,906  1,953  1,706  1,742  1,789  1,628  1,809  1,718  1,759  1,731  1,557  1,659  1,615  1,709  1,437  1,447  1,321  1,610  635  723  685 
Accrued compensation 2,099  1,909  1,773  1,507  2,189  1,796  1,663  1,371  1,988  1,645  1,502  1,304  1,860  1,521  1,477  1,205  1,712  1,481  1,389  1,171  1,611  1,005  806  787 
Accrued income taxes 502  457  442  500  567  648  536  784  979  925  872  717  633  821  —  —  —  —  —  —  —  —  —  — 
Deferred tax liabilities —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  142  120  119  17  18  19 
Other accrued expenses 2,993  3,580  3,115  3,147  2,925  3,347  3,179  3,623  3,431  3,652  3,273  3,251  2,442  2,547  3,098  3,129  2,751  3,070  2,990  3,198  3,399  1,771  1,435  1,465 
Current liabilities held for sale —  —  —  —  —  —  —  —  —  —  —  59  34  —  —  —  —  —  —  —  —  —  —  — 
Current liabilities 10,366  8,735  8,170  8,518  8,472  8,853  8,463  9,112  10,084  10,933  10,496  15,148  14,220  12,672  9,601  7,896  7,165  8,141  8,126  7,660  9,173  5,613  6,952  5,433 
Long-term debt 22,021  24,732  24,752  24,804  24,486  23,674  23,673  23,678  23,699  25,918  25,941  25,953  25,921  25,923  29,010  30,124  30,247  33,681  33,690  33,709  33,752  26,641  9,708  10,323 
Accrued compensation and retirement benefits 1,910  1,598  1,573  1,640  1,651  1,313  1,301  1,412  1,425  1,524  1,475  1,663  1,641  1,610  1,768  1,770  1,759  1,585  1,577  1,549  1,535  671  681  680 
Accrued income taxes 2,682  2,738  2,705  2,873  2,838  2,874  2,950  3,042  3,051  4,758  2,194  2,170  2,405  2,527  2,381  2,344  2,903  2,822  2,771  2,541  2,476  1,405  1,322  1,251 
Deferred tax liabilities 1,174  1,282  1,376  1,346  1,278  1,356  1,325  1,347  1,423  1,363  1,841  2,610  2,978  3,643  3,754  3,790  3,729  3,802  4,766  4,701  4,700  415  420  377 
Other liabilities 1,664  1,784  1,758  1,590  757  719  724  801  889  964  933  1,026  1,515  1,710  1,599  1,785  1,916  1,859  1,746  1,657  1,819  315  259  242 
Noncurrent liabilities held for sale —  —  —  —  —  —  —  —  —  —  —  893  720  —  —  —  —  —  —  —  —  —  —  — 
Noncurrent liabilities 29,451  32,134  32,164  32,253  31,010  29,936  29,973  30,280  30,487  34,527  32,384  34,315  35,180  35,413  38,512  39,813  40,554  43,749  44,550  44,157  44,282  29,447  12,390  12,873 
Total liabilities 39,817  40,869  40,334  40,771  39,482  38,789  38,436  39,392  40,571  45,460  42,880  49,463  49,400  48,085  48,113  47,709  47,719  51,890  52,676  51,817  53,455  35,060  19,342  18,306 
Ordinary shares, par value $0.0001 —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  99  98  99 
Additional paid-in capital 26,165  26,144  26,171  26,470  26,532  26,518  27,048  27,817  28,127  28,190  28,091  28,553  29,551  —  —  —  —  —  —  —  —  —  —  — 
Retained earnings 28,132  28,210  27,018  26,377  26,270  25,769  25,171  24,730  24,379  23,426  25,438  24,043  23,356  52,266  52,514  52,848  53,931  53,781  53,740  54,165  54,414  20,735  19,846  19,637 
Accumulated other comprehensive loss (3,560) (2,546) (2,611) (2,484) (2,711) (2,458) (2,612) (2,323) (1,786) (1,382) (2,060) (1,924) (2,613) (2,879) (2,328) (2,024) (1,868) (2,965) (1,471) (1,356) (1,184) (661) (506) (488)
Shareholders’ equity 50,737  51,808  50,578  50,363  50,091  49,829  49,607  50,224  50,720  50,234  51,469  50,672  50,294  49,387  50,186  50,824  52,063  50,816  52,269  52,809  53,230  20,173  19,438  19,248 
Noncontrolling interests 135  145  141  134  121  112  107  105  102  106  109  115  122  106  107  68  —  —  —  —  —  —  —  — 
Total equity 50,872  51,953  50,719  50,497  50,212  49,941  49,714  50,329  50,822  50,340  51,578  50,787  50,416  49,493  50,293  50,892  52,063  50,816  52,269  52,809  53,230  20,173  19,438  19,248 
Total liabilities and equity 90,689  92,822  91,053  91,268  89,694  88,730  88,150  89,721  91,393  95,800  94,458  100,250  99,816  97,578  98,406  98,601  99,782  102,706  104,945  104,626  106,685  55,233  38,780  37,554 

Based on: 10-K (filing date: 2020-06-19), 10-Q (filing date: 2020-02-28), 10-Q (filing date: 2019-12-03), 10-Q (filing date: 2019-08-30), 10-K (filing date: 2019-06-21), 10-Q (filing date: 2019-03-01), 10-Q (filing date: 2018-11-29), 10-Q (filing date: 2018-08-31), 10-K (filing date: 2018-06-22), 10-Q (filing date: 2018-03-02), 10-Q (filing date: 2017-12-04), 10-Q (filing date: 2017-09-01), 10-K (filing date: 2017-06-27), 10-Q (filing date: 2017-03-03), 10-Q (filing date: 2016-12-05), 10-Q (filing date: 2016-09-07), 10-K (filing date: 2016-06-28), 10-Q (filing date: 2016-03-09), 10-Q (filing date: 2015-12-09), 10-Q (filing date: 2015-09-09), 10-K (filing date: 2015-06-23), 10-Q (filing date: 2015-02-27), 10-Q (filing date: 2014-11-26), 10-Q (filing date: 2014-08-29).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Medtronic PLC’s current liabilities increased from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020.
Noncurrent liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Medtronic PLC’s noncurrent liabilities decreased from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Medtronic PLC’s total liabilities increased from Q2 2020 to Q3 2020 but then decreased significantly from Q3 2020 to Q4 2020.
Shareholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity’s stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Medtronic PLC’s shareholders’ equity increased from Q2 2020 to Q3 2020 but then slightly decreased from Q3 2020 to Q4 2020 not reaching Q2 2020 level.